Drug Type Stem cell therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Hepatx Corp.Startup |
Active Organization Hepatx Corp.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alpha 1-Antitrypsin Deficiency | Preclinical | US | Hepatx Corp.Startup | 18 Aug 2023 |
Phenylketonurias | Preclinical | US | Hepatx Corp.Startup | 18 Aug 2023 |